Urgent

Cold agglutinin disease (acute haemolysis)

Haemolytic anaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Autoimmune haemolysis from cold-reactive (usually IgM) antibodies agglutinating red cells at low temperatures, causing acrocyanosis and complement-mediated haemolysis. Primary or secondary to infection (mycoplasma, EBV) or lymphoma.

Red flags

  • Rapidly falling haemoglobin / haemodynamic compromise
  • Haemoglobinuria
  • Cold exposure precipitating crisis

Assessment

Differential diagnosis

  • Warm autoimmune haemolytic anaemia
  • Paroxysmal cold haemoglobinuria
  • Microangiopathic haemolysis (TTP/HUS)
  • Raynaud phenomenon

Investigations

  • FBC and blood film (agglutination, spherocytes), reticulocytes
  • Direct antiglobulin test (positive for C3d), cold agglutinin titre
  • LDH (raised), haptoglobin (low), bilirubin
  • Screen for underlying infection/lymphoproliferative disorder

Management

  • Keep the patient warm (including limbs, environment and any IV fluids/blood)
  • Treat any underlying trigger (infection, lymphoma)
  • Transfuse only if necessary, using a blood warmer and warmed products
  • For significant primary disease: consider rituximab-based therapy
  • Avoid steroids/splenectomy as first line (less effective than in warm AIHA)

Drugs & doses

Warming measures and warmed IV fluids/blood
Rituximab (mainstay for treatment-requiring primary disease)
Complement inhibition (e.g. sutimlimab) in specialist settings
Folic acid supplementation

Disposition

Admit for significant haemolysis; haematology involvement and treatment of any underlying cause.

Complications & pitfalls

  • Severe anaemia
  • Acrocyanosis/tissue ischaemia
  • Transfusion difficulties from agglutination

Exam pearls

  • Keeping the patient warm is a key intervention - including warming transfused blood and IV fluids.
  • Corticosteroids and splenectomy are much less effective than in warm AIHA; rituximab is preferred.
  • Cross-matching is difficult due to agglutination - liaise closely with the blood bank.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.